Fig. 5.
Schematic representation of the active targeting mechanisms of A7R-modified nanocarriers. A7R can guide nanocarriers to bind endothelial cells and tumor cells that express NRP-1 or VEGFR-2.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.